chr2-31188329-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145122.2(CAPN14):c.1519G>A(p.Val507Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000348 in 1,551,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145122.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAPN14 | ENST00000403897.4 | c.1519G>A | p.Val507Ile | missense_variant | Exon 14 of 22 | 2 | NM_001145122.2 | ENSP00000385247.3 | ||
| CAPN14 | ENST00000398824.6 | n.*950G>A | non_coding_transcript_exon_variant | Exon 14 of 22 | 2 | ENSP00000381805.2 | ||||
| CAPN14 | ENST00000398824.6 | n.*950G>A | 3_prime_UTR_variant | Exon 14 of 22 | 2 | ENSP00000381805.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000128 AC: 2AN: 156498 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000357 AC: 50AN: 1399244Hom.: 0 Cov.: 33 AF XY: 0.0000246 AC XY: 17AN XY: 690132 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1519G>A (p.V507I) alteration is located in exon 14 (coding exon 13) of the CAPN14 gene. This alteration results from a G to A substitution at nucleotide position 1519, causing the valine (V) at amino acid position 507 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at